Bayer Pharma Head Tapped to Replace Oxford GlycoSciences CEO | GenomeWeb

NEW YORK, May 24 - Oxford GlycoSciences today said it has hired David Ebsworth to take over the CEO post after Michael Kranda leaves on July 11.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.